It is worth mentioning that the data pointed to a modest decrease in the likelihood of testing positive for SARS-CoV-2, but not the severity in patients taking beta-blockers, that was slightly significant in an analysis that included all matched patients.
← all excerpts
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19.
1
—
—